- Home
- MTNB vs SGLY Comparison
MTNB vs SGLY Comparison
Compare MTNB & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- SGLY
- Stock Information
- Founded
- MTNB 2013
- SGLY 2001
- Country
- MTNB United States
- SGLY United States
- Employees
- MTNB N/A
- SGLY N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- MTNB Health Care
- SGLY
- Exchange
- MTNB Nasdaq
- SGLY Nasdaq
- Market Cap
- MTNB 3.1M
- SGLY 3.0M
- IPO Year
- MTNB N/A
- SGLY 2008
- Fundamental
- Price
- MTNB $0.71
- SGLY $1.19
- Analyst Decision
- MTNB Hold
- SGLY
- Analyst Count
- MTNB 1
- SGLY 0
- Target Price
- MTNB N/A
- SGLY N/A
- AVG Volume (30 Days)
- MTNB 73.5K
- SGLY 98.9K
- Earning Date
- MTNB 05-20-2025
- SGLY 05-26-2025
- Dividend Yield
- MTNB N/A
- SGLY N/A
- EPS Growth
- MTNB N/A
- SGLY N/A
- EPS
- MTNB N/A
- SGLY N/A
- Revenue
- MTNB N/A
- SGLY $2,255,541.00
- Revenue This Year
- MTNB N/A
- SGLY N/A
- Revenue Next Year
- MTNB N/A
- SGLY N/A
- P/E Ratio
- MTNB N/A
- SGLY N/A
- Revenue Growth
- MTNB N/A
- SGLY N/A
- 52 Week Low
- MTNB $0.48
- SGLY $0.54
- 52 Week High
- MTNB $9.60
- SGLY $7.65
- Technical
- Relative Strength Index (RSI)
- MTNB 63.45
- SGLY 68.22
- Support Level
- MTNB $0.57
- SGLY $0.87
- Resistance Level
- MTNB $0.65
- SGLY $1.15
- Average True Range (ATR)
- MTNB 0.07
- SGLY 0.12
- MACD
- MTNB 0.01
- SGLY 0.05
- Stochastic Oscillator
- MTNB 51.79
- SGLY 98.31
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.